Helse Forde
15
7
7
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Precision Cancer Therapy in Rare Cancers
Role: collaborator
A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease
Role: collaborator
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Role: collaborator
Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy
Role: lead
Improving Public Cancer Care by Implementing Precision Medicine in Norway
Role: collaborator
Penicillin Allergy Delabeling Project
Role: collaborator
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Role: collaborator
Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate?
Role: collaborator
The Norwegian Antirheumatic Drug Register
Role: collaborator
Accelerometry in Follow up of Arthritis - a Pilot Study
Role: lead
Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System
Role: collaborator
Genetic Mechanisms and Additional Risk Factors Underlying Hip Dysplasia
Role: collaborator
A Clinical Feedback System in Ostomy Care
Role: lead
Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
Role: collaborator
Bariatric Surgery on the West Coast of Norway (Vestlandet)
Role: collaborator
All 15 trials loaded